Canada to Speed up Reviews of Generic Medicines

Canada’s Therapeutic Products Directorate has announced that as of Feb. 1, it will be replacing the Integrated Review Process that has been used for screening generic Abbreviated New Drug Submissions and supplements with updated screening criteria.
Regulatory Focus